Modified Arm Positioning to Reduce Shoulder Pain After Thoracoscopic Lobectomy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective randomized trial will enroll 270 adults scheduled for video-assisted thoracoscopic lobectomy for lung lesions. Participants will be assigned to either the traditional arm-boards position or a modified double-arm wrap positioning during surgery. The goal is to see if the altered intraoperative arm position reduces postoperative shoulder pain without increasing complications. Outcomes will focus on pain levels on the surgical side and recovery measures in the postoperative period. The study is conducted at Chengdu Shangjin Nanfu Hospital in China with Chengdu Jinjiang Maternity and Child Health Hospital as the lead sponsor.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age ≥18 years.
2. Diagnosed with pulmonary space-occupying lesion and scheduled for elective video-assisted thoracoscopic standard lobectomy.
3. ASA physical status classification I-III.
4. No pre-existing shoulder pain or shoulder mobility impairment prior to surgery.
5. No long-term use of analgesic medications (\>1 week) before surgery.
6. Willing and able to provide written informed consent.

Exclusion Criteria:

1. Severe cervical spine disease or history of brachial plexus injury.
2. Cognitive impairment or psychiatric disorder precluding understanding of pain assessment scales.

Where it's running

• Chengdu Shangjin Nanfu Hospita
  Chengdu, Sichuan, China Recruiting

Study contacts

• Study coordinator: Lu Feng
• Email: fengluhx@163.com
• Phone: +86 15982012545

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-assisted longitudinal CT to guide indeterminate lung nodules

  This trial tests whether giving doctors an AI report that tracks nodules over serial CT scans helps reduce unnecessary benign lung resections in patients with indeterminate nodules.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07895277

• MRD-guided postoperative monitoring and adaptive treatment for resectable NSCLC

  This study tests a personalized follow-up and treatment plan using ctDNA MRD testing and pathology to guide adjuvant therapy after surgery for stage IB-IIIA NSCLC treated with neoadjuvant immunotherapy.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07894458

• Telerehabilitation exercise program after lung cancer surgery

  A remote rehabilitation program with guided exercises is tested to help adults after lung cancer surgery recover better.

  Recruiting University of Seville · Seville, Andalusia · NCT07861282

• Impact of Exercise on Tumor Immunity in NSCLC Patients Receiving Neoadjuvant Chemo-Immunotherapy

  A structured exercise program is being tested to see if it boosts immune cells in the tumor for patients with resectable NSCLC undergoing pre-surgery chemo-immunotherapy.

  Recruiting at 2 sites Centre Leon Berard · Lyon, Rhône and 1 other locations · NCT07786909

• Low-Dose CT Lung Cancer Screening in Kuwait: Feasibility and Uptake

  This pilot tests whether offering low-dose CT lung cancer screening to high-risk adults in Kuwait is workable and acceptable, with about 500 participants completing a baseline scan.

  Recruiting Chest Diseases Hospital, Ministry of Health, Kuwait · Kuwait City · NCT07766538

• Nitride-based Raman biochip for lung cancer diagnosis and monitoring

  A large observational study in Taiwan will test whether a blood-based nitride-based Raman biochip can help diagnose lung cancer and monitor patients over time.

  Recruiting Taichung Veterans General Hospital · Taichung · NCT07755020

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.